anticoagulant therapy
Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
... oral anticoagulant therapy with either warfarin or cou- marin derivatives on October 15, 2002, registered at the Outpatient Anticoagulant Clinic at the University Hospi- tal of ...
7
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
... continued therapy. In patients with unprovoked VTE, extending anticoagulant therapy beyond 3 months is recom- mended only if the associated risk of bleeding remains ...long-term therapy, with ...
12
Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan
... between anticoagulant therapy and reduced mortality only in the DIC-positive subset agreed with the findings of many observational studies and post hoc subgroup analyses of RCTs [15, 23, ...that ...
12
Original Article Genotype-based anticoagulant therapy with warfarin for atrial fibrillation
... genotype-based anticoagulant therapy with warfarin in patients with atrial ...CYP2C9) anticoagulant therapy with warfarin, whereas patients in the control group received routine warfarin ...
7
Quantitative d-dimer level and anticoagulant therapy in idiopathic intracranial hypertension
... To conclude, our study demonstrated the presence of high serum quantitative D -dimer levels among the IIH pa- tients and showed an improvement in visual assessment after 6 months in both groups of patients; more apparent ...
6
Successful anticoagulant therapy for disseminated intravascular coagulation during conservative management of placenta percreta: a case report and literature review
... Background: Placenta percreta is a rare obstetric condition associated with the risk of massive intraoperative hemorrhage. Recently, conservative management of placenta percreta has been performed to reduce maternal ...
7
Personalized versus non personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis
... Background: The quality control of oral anticoagulant therapy (OAT) during the initiation and maintenance treatment is generally poor. Physicians' ordering of OAT (especially fluindione and warfarin) can be ...
8
Anticoagulated patient’s perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy – study protocol for The Switching Study: a prospective cohort study
... Anticoagulant therapy is prescribed for millions of patient’s world-wide, most commonly for the acute treatment and long-term prevention of venous thromboembolism (VTE) and as primary and secondary ...
9
Effects of computer-assisted oral anticoagulant therapy
... oral anticoagulant therapies to improve the time to reach and the time in the TTR com- pared to traditional oral anticoagulant therapy by physi- ...
7
New options with dabigatran etexilate in anticoagulant therapy
... new anticoagulant that more closely meets the criteria for optimal antithrombotic efficacy could improve the qual- ity of ...an anticoagulant should be administered ...
11
Towards improvement of oral anticoagulant therapy
... Thrombosis, or the formation of a blood clot which hampers blood flow in a bloodvessel, is a very serious disease which can potentially be fatal. Thrombosis can occur in arteries (arterial thrombosis) as well as in veins ...
155
Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient
... to thrombosis. Third, the treatment with VKA and the placement of a TIPS did not correct impaired coagula- tion balance. However, the introduction of a therapy with LMWH (enoxaparin) was associated with clear-cut ...
5
Bleeding complications in oral anticoagulant therapy: an analysis of risk factors
... To establish the mdependent mfluence of vanous pos- sible nsk factors for the occurrence of bleeding (age, sex, target zone, coumarm derivative used, and the achieved mtensity of anticoa[r] ...
6
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
... The second placebo-controlled randomized trial was the Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) trial, in which an almost four times higher dose of eptifibatide than ...
12
Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation
... We determmed the mcidence of Overanticoagulation among outpa- tients of an anticoagulation climc Furthermore, we studied the associ- ation between Overanticoagulation and charactenstics [r] ...
6
Vitamin K and stability of oral anticoagulant therapy
... 39 of those patients had stopped their anticoagulant drug or had been given vitamin K and were censored in the analysis. At 8 weeks 14% of patients had had a low INR and at 16 weeks this was 23%. Figure 2 shows ...
111
Spontaneous Hemothorax Due to Oral Anticoagulant Therapy
... Oral anticoagulant treatment is widely used in many diseases, with warfarin being the most commonly used active ...warfarin therapy with the diagnosis of deep vein thrombosis and pulmonary ...oral ...
5
Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis
... of anticoagulant therapy needs further de- tailed evaluations, including the use of new anticoagu- lants as well as continuation of warfarin within the therapeutic ...
8
Cancer-associated thrombosis: the when, how and why
... Another randomised controlled study evaluating a direct oral anticoagulant for CAT treatment was recently published [47]. In the SELECT-D (Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight ...
11
Spontaneous pulmonary hematoma with diffuse pulmonary ossification requiring emergency treatment: a case report
... hematoma. Anticoagulant therapy, thrombocytopenia, and rare dis- eases such as Ehlers-Danlos syndrome are some of the presumed causes of spontaneous or idiopathic pulmonary hematoma ...of ...
5